Ken Griffin Eledon Pharmaceuticals, Inc. Put Options Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
Put Options
3 transactions
Others Institutions Holding ELDN
# of Institutions
32Shares Held
9.61MCall Options Held
500Put Options Held
1.4K-
Bvf Inc San Francisco, CA4.33MShares$10.3 Million0.27% of portfolio
-
Armistice Capital, LLC New York, NY2.3MShares$5.47 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA969KShares$2.31 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA652KShares$1.55 Million0.01% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT443KShares$1.05 Million0.0% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $32.7M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...